Peter Thiel-backed psychedelics start-up ATAI targets schizophrenia
LONDON - ATAI Life Science, a Peter Thiel-backed start-up, has acquired a majority stake in Recognify, a company that develops drugs to treat schizophrenia.ATAI is headquartered in Berlin and aims to manufacture psychedelics that can be…